(Health-NewsWire.Net, October 25, 2017 ) The Middle East and Africa Bovine Respiratory Disease Treatment Market has been estimated at USD 2.21 million in 2016 and is projected to reach USD 5.98 million by 2021, at a CAGR of 22.1% during the forecast period from 2016 to 2021.
Bovine respiratory disease (BRD) has a multifactorial, polymicrobial etiology. Organisms known to be related with BRD include bacteria and viruses. BRD is a shared health problem for both dairy and beef cattle, ensuing in economic loses. There are many factors that combine to cause disease. No two scenarios are precisely same but they often culminate in severe and fatal bacterial pneumonia.
Bovine respiratory disease complex (BRDC) is a substantial reason of mortality and morbidity in cattle; resulting into loss of million dollars annually for the dairy and beef industries, even with the use of vaccines and antibiotics.
Full report at: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bovine-respiratory-disease-treatment-market-913/
Market Segmentation:
By Type of Treatment • Anti-Infectious Agents • Anti-Parasiticides • Bronchodilators • Oral Rehydration Fluids • Non-Steroidal Anti-Inflammatories • Mucolytics
The Middle East and Africa Bovine respiratory disease treatment market has been segmented on the basis of type of treatment into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment. Middle-East and Africa market is geographically segmented into Middle-East and Africa.
Request sample:http://www.marketdataforecast.com/market-reports/middle-east-and-africa-bovine-respiratory-disease-treatment-market-913/request-sample
The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|